People with cancer, cancer survivors, and those with compromised immune systems and other chronic medical conditions may be at a higher risk for the more severe form of COVID-19. We want to share with you some resources to inform patients and support oncology professionals during the COVID-19 pandemic.

To address the critical unmet need in access to care for hard-to-reach populations with advanced/metastatic breast cancer (ABC/MBC), the ABC Global Alliance and Pfizer have collaborated to develop a toolkit of relevant, community-based initiatives and best practice summary documents that aims to drive collaboration across the global ABC/MBC community.

To shed light on the challenges and gaps in advanced breast cancer and inspire worldwide change within the breast cancer community, ESO worked collaboratively with Pfizer Oncology in providing the Global Status of Advanced / Metastatic Breast Cancer (MBC) 2005-2015 Decade Report.